Pulsed versus conventional radiation therapy in combination with temozolomide in a murine orthotopic model of glioblastoma multiforme

International Journal of Radiation Oncology Biology Physics

Volumn 86, Issue 5, 2013, Pages 978-985

  Lee, David Y ^a   Chunta, John L ^a   Park, Sean S ^a   Huang, Jiayi ^a   Martinez, Alvaro A ^a   Grills, Inga S ^a   Krueger, Sarah A ^a   Wilson, George D ^a   Marples, Brian ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONVENTIONAL RADIATION THERAPY; DIFFERENTIAL EFFECT; EMISSION TOMOGRAPHY; GLIOBLASTOMA MULTIFORME; IMMUNOHISTOCHEMISTRY; INTERPULSE INTERVAL; METHODS AND MATERIALS; SIGNIFICANT DIFFERENCES;

BRAIN; RADIOTHERAPY; TUMORS;

COMPUTERIZED TOMOGRAPHY;

TEMOZOLOMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DAMAGE; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG EFFICACY; GLIOBLASTOMA; IMMUNOHISTOCHEMISTRY; LOW ENERGY RADIATION; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; TREATMENT OUTCOME; TUMOR VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DACARBAZINE; DOSE FRACTIONATION; GLIOBLASTOMA; MICE; MICE, NUDE; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RANDOM ALLOCATION; TUMOR BURDEN;

EID: 84880013824     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.04.034     Document Type: Article

References (22)

1. R. Stupp, M.E. Hegi, and M.J. van den Bent Changing paradigms-an update on the multidisciplinary management of malignant glioma Oncologist 11 2006 165 180 (Pubitemid 43261763)
2. R. Stupp, M.E. Hegi, and W.P. Mason Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 2009 459 466
3. R. Stupp, W.P. Mason, and M.J. van den Bent Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996 (Pubitemid 40349501)
4. M.E. Hegi, A.C. Diserens, and T. Gorlia MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 2005 997 1003 (Pubitemid 40349502)
5. J.L. Chan, S.W. Lee, and B.A. Fraass Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy J Clin Oncol 20 2002 1635 1642 (Pubitemid 34260545)
6. D.F. Nelson, M. Diener-West, and J. Horton Combined modality approach to treatment of malignant gliomas - re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: A joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group NCI Monogr 6 1988 279 284 (Pubitemid 18048001)
7. M.T. Milano, P. Okunieff, and R.S. Donatello Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastoma Int J Radiat Oncol Biol Phys 78 2010 1147 1155
8. G.E. Sheline, W.M. Wara, and V. Smith Therapeutic irradiation and brain injury Int J Radiat Oncol Biol Phys 6 1980 1215 1228 (Pubitemid 10016476)
9. M.J. Taphoorn, R. Stupp, and C. Coens Health-related quality of life in patients with glioblastoma: A randomised controlled trial Lancet Oncol 6 2005 937 944 (Pubitemid 41685226)
10. J.B. Adkison, W. Tome, and S. Seo Reirradiation of large-volume recurrent glioma with pulsed reduced-dose-rate radiotherapy Int J Radiat Oncol Biol Phys 79 2010 835 841
11. S.S. Park, J.L. Chunta, and J.M. Robertson MicroPET/CT imaging of an orthotopic model of human glioblastoma multiforme and evaluation of pulsed low-dose irradiation Int J Radiat Oncol Biol Phys 80 2011 885 892
12. M. Jamal, B.H. Rath, and P.S. Tsang The brain microenvironment preferentially enhances the radioresistance of CD133(+) glioblastoma stem-like cells Neoplasia 14 2012 150 158
13. S. Bao, Q. Wu, and R.E. McLendon Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Nature 444 2006 756 760 (Pubitemid 44949604)
14. B. Marples, and S.J. Collis Low-dose hyper-radiosensitivity: Past, present, and future Int J Radiat Oncol Biol Phys 70 2008 1310 1318 (Pubitemid 351417777)
15. E.G. Van Meir, T. Kikuchi, and M. Tada Analysis of the p53 gene and its expression in human glioblastoma cells Cancer Res 54 1994 649 652 (Pubitemid 24068319)
16. J.A. Bertout, S.A. Patel, and M.C. Simon The impact of O2 availability on human cancer Nat Rev Cancer 8 2008 967 975
17. G.O. Ahn, and J.M. Brown Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: Role of bone marrow-derived myelomonocytic cells Cancer Cell 13 2008 193 205 (Pubitemid 351318369)
18. J.P. Greenfield, W.S. Cobb, and D. Lyden Resisting arrest: A switch from angiogenesis to vasculogenesis in recurrent malignant gliomas J Clin Invest 120 2010 663 667
19. M. Kioi, H. Vogel, and G. Schultz Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice J Clin Invest 120 2010 694 705
20. G.J. Madlambayan, J.M. Butler, and K. Hosaka Bone marrow stem and progenitor cell contribution to neovasculogenesis is dependent on model system with SDF-1 as a permissive trigger Blood 114 2009 4310 4319
21. R. Du, K.V. Lu, and C. Petritsch HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion Cancer Cell 13 2008 206 220 (Pubitemid 351318372)
22. G.O. Ahn, D. Tseng, and C.H. Liao Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment Proc Natl Acad Sci U S A 107 2010 8363 8368